How BeOne Medicines Chooses Partners
Cancer is too complex to solve alone. That’s why we partner with other companies. Watch to learn how we find the right collaborations.
“We’re open-minded in the types of deals that we would do, as long as, number one, we feel the science is great, and number two, it helps to accelerate access to medicines.”
Why Partnerships Matter to BeOne Medicines
BeOne is committed to delivering innovative therapies around the world — faster, reliably, and at scale. But we can’t do it alone. Partnering with other companies is crucial to our strategy for advancing hematology-oncology, solid tumors, immune, and inflammatory diseases.
We have 45 global partnerships so far, and we’re looking for more. Find out more about our collaborations, the types of partners we’re seeking, and what we offer in return.
